Table 1 Laboratory findings on admission as well as 6 months after hospitalization
From: A case of doxorubicin and cyclophosphamide therapy-induced type 1 diabetes: a case report
On admission | 6 months after hospitalization | Normal range | |
|---|---|---|---|
WBC (/μ) | 14,300 | 4980 | 3300–8600 |
RBC (×106/μ) | 4.32 | 4.72 | 3.86–4.92 |
Hb (g/dL) | 12.5 | 12.7 | 11.6–14.8 |
Hct (%) | 36.2 | 39.3 | 35.1–44,4 |
Platelets (×103/μ) | 121.0 | 231 | 158–348 |
Blood glucose (mg/dL) | 1161 | 86 | 73–109 |
HbA1c (%) | 11.9 | 6.6 | 4.9–6.0 |
AST (U/L) | 30 | 18 | 13–30 |
ALT (U/L) | 23 | 18 | 7–23 |
γ-GT (U/L) | 61 | 23 | 9–32 |
LDH (U/L) | 461 | 154 | 124–222 |
T-bilirubin (mg/dL) | 0.4 | 0.3 | 0.4–1.5 |
ALP (U/L) | 188 | 60 | 38–113 |
BUN (mg/dL) | 88.1 | 14.7 | 8–20 |
Cre (mg/dL) | 2.14 | 0.88 | 0.46–0.79 |
Na (mEq/L) | 152 | 143 | 138–145 |
K (mEq/L) | 4.3 | 4.7 | 3.6–4.8 |
Cl (mEq/L) | 110 | 105 | 101–108 |
Acetoacetic acid (μmol/L) | 562 | NA | − 55 |
3-Hydroxybutyric acid (μmol/L) | 1208 | NA | − 85 |
Total ketone bodies (μmol/L) | 1770 | NA | − 130 |
CRP (mg/dL) | 9.82 | NA | 0.0–0.2 |
U-ketone bodies | (1+) | (−) | (−) |